Earnings Ahead

CEMI - Chembio Diagnostics, Inc.

0.455 0.001 0.22

Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc.

About

Profile


Headquarters

Medford, New York, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

CEMI



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Biosynex again extends tender offer for Chembio acquisition
  • Biosynex extends tender offer period for Chembio acquisition
  • Chembio Diagnostics jumps ~26% postmarket after Biosynex to buy co in $17.2M deal
  • Chembio Diagnostics GAAP EPS of -$0.21, revenue of $11.2M
  • Chembio gets $3.2M contract from CDC to develop rapid test for syphilis
  • Chembio stock rises 13% amid plans to develop rapid test for monkeypox
  • Chembio Diagnostics GAAP EPS of -$0.23, revenue of $9.2M
  • Chembio to self-distribute COVID test in US; offer HIV test via online platform in UK, Brazil
  • Chembio's inks contract for HIV test to be made by Reszon Diagnostics at Malaysia facility
  • Chembio Diagnostics GAAP EPS of -$0.29 misses by $0.08, revenue of $18.82M beats by $7.02M
  • Chembio Diagnostics Q1 2022 Earnings Preview
  • Chembio Diagnostics GAAP EPS of $0.47 beats by $0.67, revenue of $20.6M beats by $7.05M
  • Chembio Diagnostics Q4 2021 Earnings Preview
  • Chembio Diagnostics appoints CFO
  • Chembio Diagnostics drops 20% after FDA declined to review EUA application for COVID/Flu test
  • Chembio submits De Novo request SARS-CoV-2 Antigen test system
  • Chembio submits De Novo request SARS-CoV-2 Antigen test system (duplicate)
  • Chembio Diagnostics jumps 10% after securing SAHPRA approval for DPP COVID-19 antigen test
  • Chembio Diagnostics rises 8% after-hours after submitting EUA for COVID test
  • Chembio Diagnostics EPS misses by $0.04, beats on revenue
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
November 4, 2021 -0.24 / -0.19 12.06M / 12.46M
August 5, 2021 -0.45 / -0.3667 6.46M / 7M
May 6, 2021 -0.22 / -0.3167 8.72M / 8.19M Beat!
March 11, 2021 -0.35 / -0.2767 10.23M / 5.78M Beat!
November 5, 2020 -0.28 / -0.2825 10.27M / 4.25M Beat!
August 6, 2020 -0.42 / -0.4 5.11M / 6.88M
May 4, 2020 -0.29 / -0.23 6.86M / 7.72M
March 12, 2020 -0.23 / -0.25 6.9M / 8.56M
November 7, 2019 -0.22 / -0.17 9.72M / 9.9M
Date Price Open High Low Vol Change ER
May 5 0.669 0.625
0.672
0.620
282.93K 8.78%
May 4 0.615 0.564
0.630
0.560
89.25K 8.41%
May 3 0.567 0.550
0.599
0.550
112.35K -0.87%
May 2 0.572 0.530
0.580
0.530
171.03K -0.59%
Apr 29 0.576 0.630
0.643
0.553
270.14K -4.7%
 
Apr 28 0.604 0.626
0.630
0.600
94.37K -2.72%
Apr 27 0.621 0.626
0.653
0.612
111.89K -0.86%
Apr 26 0.626 0.670
0.700
0.620
123.19K -2.88%
Apr 25 0.645 0.670
0.670
0.640
141.93K -3.36%
Apr 22 0.667 0.691
0.700
0.660
154.95K -3.42%
Apr 21 0.691 0.701
0.710
0.691
167.47K -2.91%
Apr 20 0.712 0.755
0.780
0.695
443.42K -9.22%
Apr 19 0.784 0.740
0.790
0.730
175.15K 6.58%
Apr 18 0.736 0.731
0.753
0.701
298.93K -3.1%
Apr 14 0.759 0.760
0.768
0.736
144.79K -1.99%
Apr 13 0.775 0.732
0.783
0.732
142.64K 3.27%
Apr 12 0.750 0.757
0.800
0.727
754.72K 3.02%
Apr 11 0.728 0.741
0.770
0.701
182.46K -1.05%
Apr 8 0.736 0.761
0.776
0.732
151.62K -3.35%
Apr 7 0.761 0.770
0.770
0.732
118.89K 1.45%
Apr 6 0.750 0.750
0.770
0.732
94.03K -1.79%